Literature DB >> 25597307

Coordination and propulsion and non-propulsion phases in 100 meter breaststroke swimming.

Marek Strzała1, Piotr Krężałek2, Katarzyna Kucia-Czyszczoń1, Andrzej Ostrowski1, Arkadiusz Stanula3, Anna K Tyka4, Andrzej Sagalara5.   

Abstract

PURPOSE: The main purpose of this study was to analyze the coordination, propulsion and non-propulsion phases in the 100 meter breaststroke race.
METHODS: Twenty-seven male swimmers (15.7 ± 1.98 years old) with the total body length (TBL) of 247.0 ± 10.60 [cm] performed an all-out 100 m breaststroke bout. The bouts were recorded with an underwater camera installed on a portable trolley. The swimming kinematic parameters, stroke rate (SR) and stroke length (SL), as well as the coordination indices based on propulsive or non-propulsive movement phases of the arms and legs were distinguished.
RESULTS: Swimming speed (V100surface breast) was associated with SL (R = 0.41, p < 0.05) and with TBL tending towards statistical significance (R = 0.36, p < 0.07), all relationships between the selected variables in the study were measured using partial correlations with controlled age. SL interplayed negatively with the limbs propulsive phase Overlap indicator (R = -0.46, p < 0.05), but had no significant relationship to the non-propulsion Glide indicator.
CONCLUSIONS: The propulsion in-sweep (AP3) phase of arms and their non-propulsion partial air recovery (ARair) phase interplayed with V100surface breast (R = 0.51, p < 0.05 and 0.48 p < 0.05) respectively, displaying the importance of proper execution of this phase (AP3) and in reducing the resistance recovery phases in consecutive ones.

Entities:  

Mesh:

Year:  2014        PMID: 25597307

Source DB:  PubMed          Journal:  Acta Bioeng Biomech        ISSN: 1509-409X            Impact factor:   1.073


  1 in total

1.  Accelerometer profile of motion of the pelvic girdle in breaststroke swimming.

Authors:  Zbigniew Staniak; Krzysztof Buśko; Michał Górski; Anna Pastuszak
Journal:  J Hum Kinet       Date:  2016-09-10       Impact factor: 2.193

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.